cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
about
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAPHippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancerThe Roles of NDR Protein Kinases in Hippo SignallingMechanisms of Hippo pathway regulationEmerging role of Hippo pathway in gastric and other gastrointestinal cancersYAP and TAZ: a nexus for Hippo signaling and beyondHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerAdhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.The Hippo-YAP signaling pathway and contact inhibition of growth.Angiomotins link F-actin architecture to Hippo pathway signaling.Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase CascadeOn human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathwayNDR functions as a physiological YAP1 kinase in the intestinal epithelium.Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis.A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasisA basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemnessRole of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.The Hippo signal transduction network for exercise physiologistsLATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.Multiple Mechanisms Cooperate to Constitutively Exclude the Transcriptional Co-Activator YAP from the Nucleus During Murine Oogenesis.Hippo pathway effector Yap promotes cardiac regenerationAn evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2Disease implication of hyper-Hippo signalling.AKAP signaling complexes: pointing towards the next generation of therapeutic targets?Regulation of the Hippo pathway and implications for anticancer drug development.Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway.Bile acids activate YAP to promote liver carcinogenesis.A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.The Hippo signaling pathway provides novel anti-cancer drug targets.Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.Mutual regulation between Hippo signaling and actin cytoskeletonThe mammalian Hippo pathway: regulation and function of YAP1 and TAZ.The regulation and function of YAP transcription co-activator.G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.MRTF potentiates TEAD-YAP transcriptional activity causing metastasis.Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.The hippo signaling pathway: implications for heart regeneration and disease.Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network.
P2860
Q24298571-00F9A1F8-6D75-4B66-8AB2-283DE405D1E5Q24338421-B369CF69-5678-4452-8D3D-C8906F4BFE87Q26746889-B4DC62EE-EFED-47FB-AEDE-9A5012D8A001Q26771285-0FDE7F3B-EAEF-4A49-BEB0-86E57E19EF63Q26774473-18DC993D-E1BA-4460-B43E-3E98129D389DQ28085636-2D1E945C-296C-43E6-B802-F8BE203E4BC0Q28269498-F8FA6BE8-E7AC-4B94-A9A2-77A53F6FC6C4Q30278951-34874A52-BCA6-4A7A-8D89-E57FAE896BE7Q30408095-D9C852AD-EDB8-43F2-B551-CE92D3222F30Q33604410-233E73CD-F776-42E3-BFB6-085B544BFF01Q34493871-AAC5F8B3-0B21-4F7A-913E-66D96FA28256Q35232473-8A40E06A-DF63-49AB-B699-768B21D8070CQ35236207-C50AB52D-9ADE-468C-9218-9D38B2FC84FCQ35591698-A23C1921-98CC-40CE-9D50-9F852AA166A1Q35667652-8694399A-4050-43CE-94C0-59B4745431A6Q35829995-71FF99D8-11F9-47B5-A7A3-33DEDE311508Q36438072-9E445F22-C404-4B42-AB06-A2EEEB5A6F46Q36478653-3E026827-A520-4F24-B46C-9A4ABCB6FCE1Q36902243-8F07C605-300C-47F9-88B9-877E5CA9D36EQ37061204-9D48B1C7-46D9-46F8-9F6E-416C1B269DF0Q37082068-902F770F-7F61-4CAB-B55A-942D950B9218Q37117699-672F1FA9-E01C-4C45-A1A0-FE1220CD9929Q37269215-120CC293-5C9D-4985-9051-7726291A5281Q37385782-BB1FD768-3756-4C1C-ABE0-DE27BB0DB8FFQ37427846-87500960-0633-4D00-A14B-4B2B28AB7EA8Q37593084-1F0E4E1F-40A5-47D5-B11B-E9A79F650C3CQ37622617-D1AA139C-44B8-4027-8463-9E4F6AF093D6Q37629024-234B8D86-292F-4827-BF73-56E0BA026C13Q37651886-B6BBE79F-B02A-4929-AE3E-FC680E5FD77AQ37656609-38B02B07-F91F-49C7-9334-FC6C0169CB8FQ37716667-7345A642-5DEA-41CB-8534-5A4C0500A847Q38132299-32BCC4D5-301C-45AF-8EC2-30236DCFFD4EQ38163892-106A456A-CD5C-44EA-9786-C078F2C39C01Q38255378-4FB6271E-DD22-4C34-933A-02777B779A16Q38285451-763D5D44-5BA7-4655-A525-FEBBA115C17CQ38285829-6D836984-20B4-40DB-9D10-19BB81A89395Q38724065-50227F31-7C1D-4038-B1D0-A60CF83B866CQ38730228-237C0B17-14EB-4610-BFA6-75C19DB2EB4BQ38757064-09BDBA72-454B-415B-9750-2AD62BAC5F69Q38857144-5C4F9D72-6639-45DE-9155-9664A8BF4D19
P2860
cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
cAMP/PKA signalling reinforces ...... to actin cytoskeletal changes.
@en
type
label
cAMP/PKA signalling reinforces ...... to actin cytoskeletal changes.
@en
prefLabel
cAMP/PKA signalling reinforces ...... to actin cytoskeletal changes.
@en
P2093
P2860
P356
P1433
P1476
cAMP/PKA signalling reinforces ...... to actin cytoskeletal changes
@en
P2093
Minchul Kim
Seunghee Lee
Shinji Kuninaka
Sookyung Lee
P2860
P304
P356
10.1038/EMBOJ.2013.102
P407
P577
2013-05-03T00:00:00Z